Upcoming event
Advanced Prostate Cancer Consensus Conference (APCCC)
Back

Tag: BRCA2

Interim results from the IMPACT study: evidence for prostate-specific antigen screening in BRCA2 mutation carriers

Prostate cancer risks for male BRCA1 and BRCA2 mutation carriers: A prospective cohort study